tiprankstipranks
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
Want to see AKBA full AI Analyst Report?

Compare Akebia Therapeutics (AKBA) vs. Competitors

1,637 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Akebia Therapeutics
$1.40
$402.38M
-8.72
-38.78%
3 Buy
0 Hold
0 Sell
Strong Buy
Oruka Therapeutics
$68.92
$3.98B
-13.94
520.54%
13 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$17.23
$870.75M
3.90
63.07%
3 Buy
3 Hold
0 Sell
Moderate Buy
Vir Biotechnology
$10.75
$1.64B
-4.89
65.26%
8 Buy
0 Hold
0 Sell
Strong Buy
ProKidney
$2.18
$567.69M
-3.93
138.28%
2 Buy
2 Hold
1 Sell
Hold
ArriVent BioPharma, Inc.
$29.64
$1.41B
-5.44
42.63%
9 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBA
Akebia Therapeutics
1.50
-0.82
-35.34%
ORKA
Oruka Therapeutics
66.46
57.17
615.39%
TBPH
Theravance Biopharma
16.91
6.82
67.59%
VIR
Vir Biotechnology
10.18
4.55
80.82%
PROK
ProKidney
1.88
1.19
172.46%
AVBP
ArriVent BioPharma, Inc.
30.38
10.69
54.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts